BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.436, Protect Medical Innovation Act of 2011 Corporate tax issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY New | — |
| ELIZABETH WOODY | — |
Health Issues HCR
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY New | — |
| ELIZABETH WOODY | — |
Budget/Appropriations BUD
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, NIH, CDC, Global Health Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, NIH, CDC, Global Health Funding PL 112-025, Budget Control Act of 2011, issues related to NIH funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.